Skip Navigation

Masks Strongly Recommended but Not Required in Maryland, Starting Immediately

Due to the downward trend in respiratory viruses in Maryland, masking is no longer required but remains strongly recommended in Johns Hopkins Medicine clinical locations in Maryland. Read more.

Find a Doctor

Find a Researcher

Raul Nestor Mandler, M.D.

Headshot of Raul Nestor Mandler

Specializes in: Adolescents (12-18 years), Adults (18+ years)

Male

Languages: English, French, Hebrew, Italian, Portuguese, Spanish

Expertise

Alzheimer's Disease (AD), Multiple Sclerosis, Neurology, Parkinson's Disease, Peripheral Neuropathies ...read more

Insurance Information

Locations

Raul Mandler, MD

Appointment Phone: 240-395-2380
6000 Executive Boulevard
Suite 302
Rockville, MD 20852
Phone: 240-395-2380
Raul Mandler, MD - Google Maps

Background

Dr. Raul Mandler received his medical degree with honors from the University of Buenos Aires Facultad de Medicina, in Argentina. After moving to the United States, he performed his residency at the Cleveland Clinic, in Cleveland, OH. There, he received the International Travel Fellowship Award, given to a distinguished clinical researcher. He visited Oxford University (UK), La Salpêtrière Hospital (France), and worked at the Weizmann Institute of Science (Israel). Later, he became the first neuroimmunology Fellow of the Cleveland Clinic and then a Senior Staff Fellow at the National Institute for Neurological Disorders and Stroke (NINDS/NIH), where he dedicated close to half a decade to neuroimmunology and neurophysiology clinical research. 

Dr. Mandler was appointed Assistant Professor of Neurology and Neurosciences at the University of New Mexico, where he obtained tenure as an Associate Professor of Medicine. During this time, Dr. Mandler was awarded a full year sabbatical at the University of California.  He moved with his family to Washington, D.C., to become a Professor of Neurology at the George Washington University. There, he continued his medical practice and served as the Director for the MS/ALSA clinics.

Dr. Mandler now holds a private practice in North Bethesda where he specializes in Multiple Sclerosis, Alzheimer’s Disease, Parkinson’s Disease, EMG, Peripheral Neuropathies, Headaches, and General Clinical Neurology.

...read more

Departments / Divisions

  • Medicine at Suburban Hospital

Education

Degrees

  • MD; Universidad de Buenos Aires (1976)

Residencies

  • Internal Medicine; Kaplan Medical Center (1979)
  • Neurology; The Childrens Hospital at the Cleveland Clinic (1982)

Fellowships

  • Immunology; National Institutes of Health (1987)
  • Immunology; The Childrens Hospital at the Cleveland Clinic (1983)

Board Certifications

  • American Board of Psychiatry And Neurology (Neurology) (1984)

Research & Publications

Selected Publications

Sanjuan PM, Rice SL, Witkiewitz K, Mandler RN, Crandall C, Bogenschutz MP. Alcohol, tobacco, and drug use among emergency department patients. Drug Alcohol Depend. 2014 May 1;138:32-8. doi: 10.1016 j.drugalcdep.2014.01.025. Epub 2014 Feb 12. PubMed PMID: 24594289.

Metsch LR, Feaster DJ, Gooden L, Schackman BR, Matheson T, Das M, Golden MR, Huffaker S, Haynes LF, Tross S, Malotte CK, Douaihy A, Korthuis PT, Duffus WA, Henn S, Bolan R, Philip SS, Castro JG, Castellon PC, McLaughlin G, Mandler RN, Branson B, Colfax GN. Effect of risk-reduction counseling with rapid HIV testing  on risk of acquiring sexually transmitted infections: the AWARE randomized clinical trial. JAMA. 2013 Oct 23;310(16):1701-10. doi: 10.1001/jama.2013.280034. PubMed PMID: 24150466.

Donovan DM, Bogenschutz MP, Perl H, Forcehimes A, Adinoff B, Mandler R, Oden N, Walker R. Study design to examine the potential role of assessment reactivity  in the Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED) protocol. Addict Sci Clin Pract. 2012 Aug 28;7(1):16. doi: 10.1186/1940-0640-7-16. PubMed PMID: 23186329; PubMed Central PMCID: PMC3599426.

Metsch LR, Feaster DJ, Gooden L, Matheson T, Mandler RN, Haynes L, Tross S, Kyle T, Gallup D, Kosinski AS, Douaihy A, Schackman BR, Das M, Lindblad R, Erickson S, Korthuis PT, Martino S, Sorensen JL, Szapocznik J, Walensky R, Branson B, Colfax GN. Implementing Rapid HIV Testing With or Without Risk-Reduction Counseling in Drug Treatment Centers: Results of a Randomized Trial. Am J Public Health. 2012 Jun;102(6):1160-1167. Epub 2012 Apr 19. PubMed PMID: 22515871.

Korthuis PT, Feaster DJ, Gomez ZL, Das M, Tross S, Wiest K, Douaihy A, Mandler RN, Sorensen JL, Colfax G, McCarty D, Cohen SE, Penn PE, Lape D, Metsch LR. Injection behaviors among injection drug users in treatment: the role of hepatitis C awareness. Addict Behav. 2012 Apr;37(4):552-5. Epub 2011 Dec 14. PubMed PMID: 22209655; PubMed Central PMCID: PMC3288438.

Popescu BF, Parisi JE, Cabrera-Gómez JA, Newell K, Mandler RN, Pittock SJ, Lennon VA, Weinshenker BG, Lucchinetti CF. Absence of cortical demyelination in neuromyelitis optica.Neurology. 2010 Dec 7;75(23):2103-9. PubMed PMID: 21135384; PubMed Central PMCID: PMC2995539.

 

Bogenschutz MP, Donovan DM, Adinoff B, Crandall C, Forcehimes AA, Lindblad R, Mandler RN, Oden NL, Perl HI, Walker R. Design of NIDA CTN Protocol 0047: screening, motivational assessment, referral, and treatment in emergency departments (SMART-ED). Am J Drug Alcohol Abuse. 2011 Sep;37(5):417-25. PubMed PMID: 21854285; PubMed Central PMCID: PMC3168577.

Tross S, Campbell AN, Calsyn DA, Metsch LR, Sorensen JL, Shoptaw S, Haynes L, Woody GE, Malow RM, Brown LS Jr, Feaster DJ, Booth RE, Mandler RN, Masson C, Holmes BW, Colfax G, Brooks AJ, Hien DA, Schackman BR, Korthuis PT, Miele GM; Clinical Trials Network HIV Special Interest Group. NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs. Am J Drug Alcohol Abuse. 2011 Sep;37(5):283-93. PubMed PMID: 21854270.

Koroshetz WJ; NIH Task Force on Research in Emergency Setting. NIH and research in the emergency setting: progress, promise, and process. Ann Emerg Med. 2010 Nov;56(5):565-7. PubMed PMID: 21036296.

 

D'Onofrio G, Jauch E, Jagoda A, Allen MH, Anglin D, Barsan WG, Berger RP, Bobrow BJ, Boudreaux ED, Bushnell C, Chan YF, Currier G, Eggly S, Ichord R, Larkin GL, Laskowitz D, Neumar RW, Newman-Toker DE, Quinn J, Shear K, Todd KH, Zatzick D; Roundtable External Participants and Roundtable Steering Committee and Federal Participants. NIH Roundtable on Opportunities to Advance Research on Neurologic and Psychiatric Emergencies. Ann Emerg Med. 2010 Nov;56(5):551-64. PubMed PMID: 21036295.

Booth RE, Campbell BK, Mikulich-Gilbertson SK, Tillotson CJ, Choi D, Robinson J, Calsyn DA, Mandler RN, Jenkins LM, Thompson LL, Dempsey CL, Liepman MR, McCarty D. Reducing HIV-related risk behaviors among injection drug users in residential detoxification. AIDS Behav. 2011 Jan;15(1):30-44. PubMed PMID: 20652630; PubMed Central PMCID: PMC3023839.

 

Calsyn DA, Campbell AN, Crits-Christoph P, Doyle SR, Tross S, Hatch-Maillette MA, Mandler R.Men in methadone maintenance versus psychosocial outpatient treatment: differences in sexual risk behaviors and intervention effectiveness from a multisite HIV prevention intervention trial. J Addict Dis. 2010 Jul;29(3):370-82. PubMed PMID: 20635286; PubMed Central PMCID: PMC2906815.

Calsyn DA, Cousins SJ, Hatch-Maillette MA, Forcehimes A, Mandler R, Doyle SR, Woody G. Sex under the influence of drugs or alcohol: common for men in substance abuse treatment and associated with high-risk sexual behavior. Am J Addict. 2010 Mar-Apr;19(2):119-27. PubMed PMID: 20163383; PubMed Central PMCID: PMC2861416.

Tross S, Campbell AN, Cohen LR, Calsyn D, Pavlicova M, Miele GM, Hu MC, Haynes L, Nugent N, Gan W, Hatch-Maillette M, Mandler R, McLaughlin P, El-Bassel N, Crits-Christoph P, Nunes EV.Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: results of NIDA Clinical Trials Network Trial. J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):581-9. PubMed PMID: 18645513; PubMed Central PMCID: PMC2723122.

Hurwitz BJ, Jeffery D, Arnason B, Bigley K, Coyle P, Goodin D, Kaba S, Kirzinger S, Lynch S, Mandler R, Mikol D, Rammohan K, Sater R, Sriram S, Thrower B, Boateng F, Jakobs P, Wash MB, Bogumil T. Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study. Clin Ther. 2008 Jun;30(6):1102-12. PubMed PMID: 18640466.

Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.Brain. 2007 May;130(Pt 5):1194-205. Epub 2007 Feb 4. PubMed PMID: 17282996.

Mandler RN. Neuromyelitis optica – Devic’s syndrome, update. Autoimmunity Reviews 5 (2006) 537-543.

Bakay M, Wang Z, Melcon G, Schiltz L, Xuan J, Zhao P, Sartorelli V, Seo J, Pegoraro E, Angelini C, Shneiderman B, Escolar D, Chen YW, Winokur ST, Pachman LM, Fan C, Mandler R, Nevo Y, Gordon E, Zhu Y, Dong Y, Wang Y, Hoffman EP. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration.
Brain. 2006 Apr;129(Pt 4):996-1013.

Panitch HS, Thisted RA, Smith RA, Wynn DR, Wymer JP, Achiron A, Vollmer TL, Mandler RN, Dietrich DW, Fletcher M, Pope LE, Berg JE, Miller A; Pseudobulbar Affect in Multiple Sclerosis Study Group. Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis.
Ann Neurol. 2006 May;59(5):780-7. 

Foster D, Falah M, Kadom N, Mandler R.  Wernicke encephalopathy after bariatric surgery: losing more than just weight. Neurology 2005; 65: 1987 (discussion 1847).

Russo MJ, Firestone LB, Mandler RN, Kelly JJ. Nerve conduction studies of the lateral femoral cutaneous nerve. Implications in the diagnosis of meralgia paresthetica. Am J Electroneurodiagnostic Technol 2005; 45:180-185.

Mitsumoto H, Bromberg M, Johnston W, Tandan R, Byock I, Lyon M, Miller RG, Appel SH, Benditt J, Bernat JL, Borasio GD, Carver AC, Clawson L, Del Bene ML, Kasarskis EJ, LeGrand SB, Mandler R, McCarthy J, Munsat T, Newman D, Sufit RL, Versenyi A. Promoting excellence in end-of-life care in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2005; 6(3): 145-154.

Roh ML, Tuazon CU, Mandler R, Kwon-Chung KJ, Geist CE. Sphenocavernous syndrome associated with Schizophyllum commune infection of the sphenoid sinus. Ophthal Plast Reconstr Surg. 2005 Jan;21(1):71-4.

Cudkowicz ME, Shefner JM, Schoenfeld DA, Brown RH Jr, Johnson H, Qureshi M, Jacobs M, Rothstein JD, Appel SH, Pascuzzi RM, Heiman-Patterson TD, Donofrio PD, David WS, Russell JA, Tandan R, Pioro EP, Felice KJ, Rosenfeld J, Mandler RN, Sachs GM, Bradley WG, Raynor EM, Baquis GD, Belsh JM, Novella S, Goldstein J, Hulihan J; Northeast ALS Consortium. A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology. 2003 Aug 26;61(4):456-64.

Wilken JA, Kane R, Sullivan CL, Wallin M, Usiskin JB, Quig ME, Simsarian J, Saunders C, Crayton H, Mandler R, Kerr D, Reeves D, Fuchs K, Manning C, Keller M. The utility of computerized neuropsychological assessment of cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. Mult Scler. 2003 Mar;9(2):119-27.

Kalman B, Mandler RN. Studies of mitochondrial DNA in Devic's disease revealed no pathogenic mutations, but polymorphisms also found in association with multiple sclerosis.
Ann Neurol. 2002 May;51(5):661-2.

The Transverse Myelitis Consortium Working Group (Mandler RN, co-PI). Proposed Diagnostic Criteria for Acute Transverse Myelitis. Neurology 2002;59:499-505.

Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002 Jul;125(Pt 7):1450-61. 

Mandler RN, Anderson FA Jr, Miller RG, Clawson L, Cudkowicz M, Del Bene M; ALS C.A.R.E. Study Group. The ALS Patient Care Database: insights into end-of-life care in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001 Dec;2(4):203-8.

Bromberg MB, Anderson F, Davidson M, Miller RG ; and The ALS CARE Study Group (Mandler RN, co-principal investigator). Assessing Health Status Quality of Life in ALS: Comparison of SIP/ALS-19 with the ALS Functional Rating Scale and the Short Form-12 Health Survey. Journal of Amyotrophic Lateral Sclerosis  and other motor neuron disorders 2001; 57:500-504.

Miller RG, Moore DH 2nd, Gelinas DF, Dronsky V, Mendoza M, Barohn RJ, Bryan W, Ravits J, Yuen E, Neville H, Ringel S, Bromberg M, Petajan J, Amato AA, Jackson C, Johnson W, Mandler R, Bosch P, Smith B, Graves M, Ross M, Sorenson EJ, Kelkar P, Parry G, Olney R; Western ALS Study Group. Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis.
Neurology. 2001 Apr 10;56(7):843-8.

Mandler RN, Dencoff JD, Midani F, Ford CC, Ahmed W, Rosenberg GA. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica. Brain. 2001 Mar;124(Pt 3):493-8. 

Miller RG, Anderson FA, Bradley WG, Bromberg MB, Brooks BR, Mitsumoto H, Munsat T, Ringel SP, and the ALS CARE Study Group (Mandler RN, co-principal investigator). The ALS patient care database: goals, design, and early results. Neurology 2000; 54 (1) 53-57.

Apfel SC, Schwartz S, Adornato BT et. al, for the rhNGF Clinical Investigator Group (Mandler RN, co-PI). Efficacy and Safety of Recombinant Human Nerve Growth Factor in Patients with Diabetic Polyneuropathy. A Randomized Controlled Trial. JAMA. 2000; 284:2215-2221.

The BDNF Study Group (Mandler RN, co-principal investigator). A controlled trial of recombinant methionyl human BDNF in ALS. Neurology 1999; 52: 1427-1433.

Mandler RN, Ahmed W, Dencoff JE. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology. 1998 Oct;51(4):1219-20.

Ross MA, Miller RG, Berchert L, Parry G, Barohn RJ, Armon C, Bryan WW, Petajan J, Stromatt S, Goodpasture J, McGuire G & the rhCNTF ALS Study Group (Mandler RN, co-principal investigator). Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria.Neurology 1998; 50: 768-772.

 

Johnson KP, Brooks BR, Cohen JA, Ford CC, Goldstein J, Lisak RP, Myers LW, Panitch HS, Rose JW, Schiffer RB, Vollmer T, Weiner LP, Wolinsky JS & the Copolymer 1 Multiple Sclerosis Study Group (Mandler RN, co-principal investigator). Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Neurology 1998; 50: 701-708.

Maselli RA, Agius M, Lee EK, Bakshi N, Mandler RN, Ellis W. Morvan's fibrillary chorea. Electrodiagnostic and . in vitro microelectrode findings. Ann N Y Acad Sci. 1998 May 13;841:497-500.

McGuire D, Garrison L, Armon C, Barohn RJ, Bryan WW, Miller R, Parry GJ, Petajan JH, Ross MA & the Syntex-Synergen ALS/CNTF Study Group (Mandler RN, co-principal investigator). A brief quality-of-life measure for ALS clinical trials based on a subset of items from the sickness impact profile. Journal of the Neurological Sciences 1997; 152: S18-S22.

Bakshi N, Maselli RA, Gospe SM Jr, Ellis WG, McDonald C, Mandler RN. Fulminant demyelinating neuropathy mimicking cerebral death. Muscle Nerve. 1997 Dec;20(12):1595-7. 

Maselli RA, Ellis W, Mandler RN, Sheikh F, Senton G, Knox S, Salari-Namin H, Agius M, Wollmann RL, Richman DP. Cluster of wound botulism in California: clinical, electrophysiologic, and pathologic study.
Muscle Nerve. 1997 Oct;20(10):1284-95. 

Cock H, Mandler R, Ahmed W, Schapira AH. Neuromyelitis optica (Devic's syndrome): no association with the primary mitochondrial DNA mutations found in Leber hereditary optic neuropathy.
J Neurol Neurosurg Psychiatry. 1997 Jan;62(1):85-7.

 

Hoagland RJ, Mendoza M, Armon C, Barohn RJ, Bryan WW, Goodpasture JC, Miller RG, Parry GJ, Petajan JH, Ross MA & the Syntex-Synergen Neuroscience Joint Venture rhCNTF ALS Study Group (Mandler RN, co-principal investigator). Reliability of maximal voluntary isometric contraction testing in a multicenter study of patients with amyotrophic lateral sclerosis. Muscle & Nerve 1997; 20: 691-695.

Mandler RN, King MK. Myeloneuropathy in POEMS syndrome. Muscle Nerve. 1996 Dec;19(12):1614-6.

Mandler RN, Maselli RA. Stimulated single-fiber electromyography in wound botulism.
Muscle Nerve. 1996 Sep;19(9):1171-3.

 

Miller RG, Petajan J, Bryan WW, et al, & the rhCNTF ALS Study Group (Mandler RN co-principal investigator). A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. Annals of Neurology 1996; 39: 256-260.

Bryan WW, Hoagland RJ, Murphy J, et al, & the rhCNTF ALS Study Group (Mandler RN, co-investigator). Comparison of natural history with placebo treatment in patients with amyotrophic lateral sclerosis. Journal of Neurological Sciences 1996.

Smith JP, Hicks PS, Ortiz LR, Martinez MJ, Mandler RN. Quantitative measurement of muscle strength in the mouse. J Neurosci Methods. 1995 Nov;62(1-2):15-9.

 

Chapin JE, Davis LE, Kornfeld M, Mandler RN. Neurologic manifestations of intravascular lymphomatosis. Acta Neurol Scand. 1995 Jun;91(6):494-9. 

Johnson KP, Brooks BR, Cohen JA, et al, & the Copolymer 1 Multiple Sclerosis Study Group (Mandler RN, co-investigator). Copolymer 1 reduces the relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. Neurology 1995; 45: 1268-1276.

Mandler RN, Platt MW & Bennahum D. Neurological aphorisms of Maimonides. Humane Medicine 1994; 10: 209-214.

Mandler RN, Davis LE, Jeffery DR, Kornfeld M. Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol. 1993 Aug;34(2):162-8. 

 

Jeffery DR, Mandler RN, Davis LE. Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events.
Arch Neurol. 1993 May;50(5):532-5. 

Mandler RN, Seamer LC, Domalewski MD, Bankhurst AD. Progesterone but not estrogen depolarizes natural killer cells. Nat Immun. 1993 May-Jun;12(3):128-35. 

Mandler RN. The Uhthoff phenomenon. Journal of Musculoskeletal Medicine 1993; 10 (10): 12-13.

Mandler RN, Kerrigan DP, Smart J, Kuis W, Villiger P, Lotz M. Castleman's disease in POEMS syndrome      with elevated interleukin-6. Cancer. 1992 Jun 1;69(11):2697-703. 

Mandler RN, Baca JM. Muscle lactate dehydrogenase activity is decreased in murine motor neuron disease.
Brain Res. 1992 Apr 3;576(2):337-8. 

Seamer LC, Mandler RN. Method to improve the sensitivity of flow cytometric membrane potential measurements in mouse spinal cord cells. Cytometry. 1992;13(5):545-52. 

Raroque HG Jr, Mandler RN, Griffey MS, Orrison WW, Kornfeld M. Neoplastic angioendotheliomatosis.
Arch Neurol. 1990 Aug;47(8):929-30.

Mandler RN, Schaffner AE, Novotny EA, Lange GD, Smith SV, Barker JL. Electrical and chemical excitability appear one week before birth in the embryonic rat spinal cord.
Brain Res. 1990 Jul 2;522(1):46-54.

Mandler RN, Seamer LC, Whitlinger D, Lennon M, Rosenberg E, Bankhurst AD. Human natural killer cells express Na+ channels. A pharmacologic flow cytometric study. J Immunol. 1990 Mar 15;144(6):2365-70. 

Mandler RN, Schaffner AE, Novotny EA, Lange GD, Barker JL. Flow cytometric analysis of membrane potential in embryonic rat spinal cord cells. J Neurosci Methods. 1988 Jan;22(3):203-13.

Mandler RN, Biddison WE, Mandler R, Serrate SA. beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells. J Immunol. 1986 Feb 1;136(3):934-9.

Valenzuela R, Mandler R, Goren H. Immunonephelometric quantitation of central nervous system IgG daily synthesis in multiple sclerosis. Clinical evaluation using predictive value theory.
Am J Clin Pathol. 1982 Jul;78(1):22-8.

Mandler R, Goren H, Valenzuela R. Value of central nervous system IgG daily synthesis determination in the diagnosis of multiple sclerosis. Neurology. 1982 Mar;32(3):296-8.

Chapters

Mandler RN. Therapy of Myopathies. In: Biller J (ed). A Practical Guide to Clinical Neurology. Lippincott-Raven, Philadelphia, pp. 522-536, 1997.

Mandler RN. Myopathies. In: Textbook of Neurosurgery. Lippincott-Raven, Philadelphia. Chapter 44, pages 641-652.

Mandler RN, Werner J, Meister M & LaFontaine G. Alternative and complementary therapies in amyotrophic lateral sclerosis. In: Mitsumoto H and Munsat T (eds). Amyotrophic Lateral Sclerosis, A Guide to Patients and Families. Demos, New York, NY, 2001, 201-209.

Mandler RN. Myopathies. In: Biller J (2nd ed). A Practical Guide to Clinical Neurology. Lippincott-Raven, Philadelphia,  2002, in press.

Mandler RN (ed). Dysfunction of the Blood-Brain Barrier in the pathogenesis of multiple sclerosis. Proceedings of the 2001Chicago International Conference Sponsored by Serono Symposia International, USA 2002, 1-16.

Books

Mandler RN (ed). Proceedings of the 1998 UNM Neurology Course in Santa Fe, UNM Department of Continuing Medical Education and the UNM Department of Neurology.

Letters

Mandler RN, Kerrigan DP, Smart J, Kuis W, Villiger P & Lotz M. Comments on Castleman's disease in POEMS syndrome with elevated IL-6. A reply. Cancer 1992; 1116.

Activities & Honors

Memberships

  • American Academy of Neurology
  • American Neurological Association
Is this you? Edit Profile
back to top button